98%
921
2 minutes
20
Objective: To systematically review the evidence on, to devise clinical recommendations for, and to identify critical knowledge gaps in resuscitation of newborn puppies and kittens.
Design: Standardized, systematic evaluation of literature pertinent to newborn resuscitation following Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Prioritized questions were reviewed by Evidence Evaluators, and findings were reconciled by Domain Chairs and Reassessment Campaign on Veterinary Resuscitation (RECOVER) Co-Chairs to arrive at treatment recommendations commensurate with the quality of evidence, risk-benefit relationship, and clinical feasibility. This process was implemented using an evidence profile worksheet for each question that included an introduction, consensus on science, treatment recommendations, justification for these recommendations, and important knowledge gaps. Treatment recommendations underwent a modified Delphi consensus process and were then distributed to veterinary professionals for comment for 2 weeks prior to finalization.
Setting: Transdisciplinary, international collaboration in university, specialty, and emergency veterinary practice.
Results: Twenty-eight questions pertaining to temperature management, respiratory and metabolic support, and CPR were addressed. Of the 59 treatment recommendations formulated, 21 concerned medications, 20 addressed respiratory measures, 20 provided guidance on CPR, and 3 related to temperature management. Taken together, the recommendations emphasize the importance of early administration of bag-mask ventilation in nonvigorous, severely bradycardic newborn puppies and kittens. Most recommendations are either expert opinion (n = 28) or based on very low quality of evidence (n = 26).
Conclusions: Significant uncertainty remains regarding most resuscitative interventions in newborn puppies and kittens at birth. However, through a comprehensive evaluation of the evidence and a consensus process that included considerations of feasibility, the resulting treatment recommendations lay the foundation for clear, actionable guidance in small animal newborn resuscitation. In addition, a list of prioritized knowledge gaps was identified to guide collaborative clinical research to overcome the significant lack of veterinary scientific data at present.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374491 | PMC |
http://dx.doi.org/10.1111/vec.70012 | DOI Listing |
Biom J
October 2025
Novella Clinical Full Service, IQVIA, Melbourne, Australia.
Phase I dose escalation trials in oncology generally aim to find the maximum tolerated dose. However, with the advent of molecular-targeted therapies and antibody drug conjugates, dose-limiting toxicities are less frequently observed, giving rise to the concept of optimal biological dose (OBD), which considers both efficacy and toxicity. The estimand framework presented in the addendum of the ICH E9(R1) guidelines strengthens the dialogue between different stakeholders by bringing in greater clarity in the clinical trial objectives and by providing alignment between the targeted estimand under consideration and the statistical analysis methods.
View Article and Find Full Text PDFBackground: This retrospective analysis is a derivative cohort study based on a prior retrospective investigation by this author group.
Objective: To assess the effect of the number of cellular and/or tissue-based product (CTP) applications on healing outcomes and wound area reduction (WAR) rates in patients with chronic wounds of multiple etiologies.
Methods: Data from a multicenter private wound care practice electronic health record database were analyzed for Medicare patients receiving CTPs from January 2018 through December 2023.
BMC Health Serv Res
September 2025
Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Seebad 82/83, Rüdersdorf, 15562, Germany.
Background: Hypertension remains a critical public health issue in Germany, affecting millions of individuals. Mobile health applications (mHealth apps) offer promising solutions for improving patient outcomes and adherence in hypertension management. Despite their advantages in healthcare, the adoption of mHealth apps by general practitioners (GPs) in Germany remains limited to date.
View Article and Find Full Text PDFInfect Dis Ther
September 2025
School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Introduction: The high mortality of Coronavirus Disease 2019 (COVID-19) highlights the need for safe and effective antiviral treatment. Small molecular antivirals (remdesivir, molnupiravir, nirmatrelvir/ritonavir) and immunomodulators (baricitinib, tocilizumab) have been developed or repurposed to suppress viral replication and ameliorate cytokine storms, respectively. Despite U.
View Article and Find Full Text PDFJ Autism Dev Disord
September 2025
The Melbourne Clinic Neuropsychology Service, 130 Church St, Richmond, Melbourne, VIC, 3121, Australia.
Investigate the utility of a neuropsychological strengths-based approach to the assessment of Autism in adults; to determine the acceptability of the approach and feedback provided to clients; and gather information about improving the assessment process for future clients. The approach was grounded in a neurodiversity-positive framework, providing diagnosis-affirming care. Participants were inpatient clients of the neuropsychology service of a private adult, mental health treatment service.
View Article and Find Full Text PDF